Rare diseases
Investigational molecules
Locations
1 Health Plaza, 07936-1016, United States
Anthos Therapeutics Inc. is active in clinical research for atrial fibrillation, with studies centered on reducing the risk of ischemic stroke and systemic embolism in patients who are not suitable candidates for standard oral anticoagulation.
The sponsor’s interest in this area reflects a focus on thromboembolic risk management in patients with cardiac rhythm disorders.
Anthos Therapeutics Inc. runs clinical trials in conditions such as Atrial fibrillation, Embolism venous, Gastrointestinal cancer metastatic, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Bulgaria
AustriaAustria
CzechiaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
